New Report Highlights Unmet Medical Needs of Six Subtypes of LGMD, Including LGMD2A/R1

Today, Coalition to Cure Calpain 3 joins five other LGMD patient organizations (collectively referred to as The LGMD Coalition) to release the ‘Voice of the Patient Report’ summarizing outcomes from the September 2022 Externally-Led Patient Focused Drug Development Meeting (EL-PFDD).

About the Report

The goal of the report is to provide the U.S. Food and Drug Administration (FDA), clinicians, medical product developers, and academic researchers an opportunity to hear perspectives from individuals with LGMD on the health effects, daily impacts, treatment goals, and decision factors considered when seeking out or selecting a treatment.

The meeting was conducted as a parallel effort to FDA’s EL-PFDD initiative to more systematically gather patients’ perspectives on their conditions and available therapies to treat their conditions.

About the LGMD Coalition

The LGMD Coalition is a group of six 501(c)3 nonprofit organizations — Coalition to Cure Calpain 3, CureLGMD2I, the Kurt+Peter Foundation, the LGMD2D Foundation, the McColl-Lockwood Laboratory for Muscular Dystrophy Research, and the Speak Foundation — that collaborated to host an LGMD EL-PFDD focused on subtypes LGMD2A/R1, LGMD2C/R5, LGMD2D/R3, LGMD2E/R4, LGMD2F/R6, and LGMD2I/R9.

The LGMD Coalition is appreciative for support from our sponsors: Sarepta Therapeutics, AskBio, Edgewise Therapeutics, ML BioSolutions, and Vita Therapeutics.

Recent Posts

  • Ruby Goldstein de Salazar Awarded C3 Travel Grant

    C3 awarded a Travel Grant to Ruby Goldstein de Salazar, a graduate student in Dr. Melissa Spencer’s laboratory at the University of California Los Angeles. Ms. Goldstein de Salazar traveled to Hiroshima, Japan in September 2026 to present her research at the 31st annual Congress of the World Muscle Society. Ms. Goldstein de Salazar’s presentation,... Read More
  • Djunda Ratenan-Peltier Awarded C3 Travel Grant

    C3 is pleased to announce that Djunda Ratenan-Peltier was awarded a Travel Grant for the presentation of her research at the international conference New Directions in Biology and Disease of Skeletal Muscle, which took place from June 7 to 10, 2026 in Fort Lauderdale, Florida. Ms. Ratenan-Peltier is a PhD student in Life Sciences at... Read More